首页> 外文期刊>Urology >Epididymitis after prostate brachytherapy.
【24h】

Epididymitis after prostate brachytherapy.

机译:前列腺近距离放射治疗后的附睾炎。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To analyze the incidence, time-course, and potential predisposing factors for what was clinically diagnosed as postimplant epididymitis. METHODS: Of 517 patients randomized and treated on two treatment protocols, with a planned total accrual of 1200, 5 patients were identified who developed clinically diagnosed epididymitis after iodine-125 or pallidium-103 prostate brachytherapy. Implants were performed by standard techniques, using a modified peripheral loading pattern. Perioperative antibiotics (cefazolin and ciprofloxacin) were given to 258 patients, according to physician preference. Treatment-related morbidity was monitored by mailed questionnaires, using standard American Urological Association (AUA) and Radiation Therapy Oncology Group criteria at 1, 3, 6, 12, and 24 months. Patients who did not respond to the mailed questionnaires were interviewed by telephone. Although the patients were not queried specifically regarding epididymitis, its occurrence was noted when discovered in the course of follow-up examinations. RESULTS: Postimplant epididymitis occurred in 5 (1%) of 517 consecutive brachytherapy patients. None of the 5 patients had had a prior history of orchitis, epididymitis, vasectomy, or preimplant catheterization. The symptoms of epididymitis first appeared at 4, 7, 10, 150, and 300 days after implantation. Patients with epididymitis had prostate volumes, preimplant AUA scores, and ages typical of other implant patients. No association was apparent between postimplant epididymitis and the degree of implant-related prostate swelling or the number of seeds implanted. Only the preimplant AUA score predicted for epididymitis, but 2 of the 5 patients had low scores. Only 1 (0.4%) of the 258 patients who received perioperative antibiotics developed epididymitis, and 4 (1.5%) of the 259 patients with prophylactic antibiotics developed epididymitis. CONCLUSIONS: Epididymitis is an uncommon postimplant complication occurring in 1% of a large patient cohort. That epididymitis patients had greater preimplant AUA scores is consistent with a retrograde infection route, at least in some cases.
机译:目的:分析在临床上被诊断为植入后附睾炎的发病率,病程和潜在诱因。方法:在517例接受两种治疗方案随机分配和治疗的患者中,计划总人数为1200名,确定了5例在碘125或钯103前列腺近距离放射治疗后发展为临床诊断的附睾炎的患者。通过标准技术,使用改良的外周负荷模式进行植入。根据医生的喜好,对258例患者进行了围手术期抗生素治疗(头孢唑林和环丙沙星)。在1、3、6、12和24个月时,采用标准的美国泌尿科协会(AUA)和放射治疗肿瘤学小组的标准,通过邮寄问卷调查与治疗相关的发病率。对邮寄问卷没有回复的患者进行电话采访。尽管没有特别询问附睾炎的患者,但是在随访检查中发现附睾炎的发生。结果:517例连续近距离放疗患者中有5例(1%)发生了植入后附睾炎。 5例患者均未曾有睾丸炎,附睾炎,输精管切除术或植入前导管插入史。附睾炎的症状首先出现在植入后的4、7、10、150和300天。附睾炎患者的前列腺体积,植入前AUA评分和其他植入患者的典型年龄。植入后附睾炎与植入物相关的前列腺肿胀程度或植入的种子数量之间没有明显联系。仅植入前的AUA评分可预测附睾炎,但5例患者中有2例评分较低。在接受围手术期抗生素治疗的258名患者中,只有1名(0.4%)患上附睾炎,而在259名预防性抗生素患者中,有4名(1.5%)患有附睾炎。结论:附睾炎是一种罕见的植入后并发症,发生在大型患者队列的1%中。附睾炎患者植入前AUA评分更高,至少在某些情况下与逆行感染途径一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号